The FDA is weighing in on the debate if Vytorin, which combines two cholesterol-fighting pills, is any more effective than just one of its ingredients used alone.
For the first time ever, a new study provides direct evidence that cholesterol-lowering drugs called statins can prevent heart attacks, strokes and deaths among women.
Use of cholesterol-lowering statins is associated with a statistically significant decline in prostate specific antigen (PSA) levels, according to a report in the October 28 online issue of the Journal of the National Cancer Institute.
